Vaccines and Autism: The Studies Behind the Claim
When someone in a debate says "there have been more than 40 studies involving 5.6 million people showing no link between vaccines and autism," it sounds like a decisive fact. And it largely is. But the natural follow-up question — can I see the list? — turns out to be surprisingly difficult to answer. No single canonical registry exists. The number is a communications estimate drawn from a broad body of research, not a formally indexed dataset.
This article assembles that research in one place, explains where it came from, who funded it, and what it actually found.
Where Does the "40 Studies / 5.6 Million People" Figure Come From?
The figure originates from the American Academy of Pediatrics (AAP), which has used it in public-facing statements and which is reproduced on their HealthyChildren.org resource pages. The AAP's own bibliography lists studies from the late 1990s through 2025, covering MMR vaccines, the preservative thimerosal (a mercury compound), cumulative vaccine antigen exposure, and vaccine schedules.
The precise count shifts depending on what you include:
- Only MMR studies, or also thimerosal, aluminum adjuvants, and vaccine schedule studies?
- Primary cohort and case-control studies only, or also systematic reviews and meta-analyses?
- Whether overlapping national datasets (e.g., multiple Danish registry studies) are counted once or separately?
The "5.6 million people" figure similarly reflects a sum across studies that may include overlapping populations — the same Danish children appearing in multiple analyses. That does not invalidate the research; it means the number is a directional estimate rather than a precise headcount of unique individuals studied.
The closest public bibliographies:
- AAP / HealthyChildren.org: Vaccine Safety — Examine the Evidence
- Autism Science Foundation: Autism and Vaccines — Read the Science
The Studies: A Clickable Reference Table
The table below covers the major primary studies and systematic reviews cited by the AAP, the Autism Science Foundation, and the WHO. It is organized by category, then chronologically. All links go to the published paper or abstract.
MMR Vaccine and Autism
| Year | Study | Journal | Population | Finding | Funding / Independence |
|---|---|---|---|---|---|
| 1998 | Peltola H, et al. — No evidence for MMR-associated IBD or autism in 14-year prospective study | The Lancet | Prospective cohort, Finland | No MMR-associated inflammatory bowel disease or autism | Finnish government / National Public Health Institute |
| 1999 | Taylor B, et al. — Autism and MMR: No epidemiological evidence for causal association | The Lancet | 498 autism cases, UK | No change in autism rates after MMR introduction; no clustering near vaccination | UK NHS / Medical Research Council |
| 2001 | Kaye JA, et al. — MMR and incidence of autism in UK general practice | BMJ | 96 PDD cases, UK | Autism likelihood same between vaccinated and unvaccinated | UK NHS / independent academic |
| 2002 | Mäkelä A, et al. — Neurologic disorders after MMR vaccination | Pediatrics | 535,544 children, Finland | No connection between MMR and encephalitis, meningitis, or autism | Finnish National Public Health Institute |
| 2002 | Madsen KM, et al. — Population-based study of MMR and autism | NEJM | 537,303 children, Denmark | No link between autism and MMR timing or date of vaccination | Danish government / Statens Serum Institut |
| 2002 | Taylor B, et al. — MMR, bowel problems, and developmental regression in autism | BMJ | 473 autism cases, UK | No evidence connecting MMR, "new variant autism," and bowel problems | UK NHS |
| 2004 | DeStefano F, et al. — Age at first MMR vaccination in children with autism, Atlanta | Pediatrics | Case-control, metropolitan Atlanta | No link between MMR timing and increased autism risk | US CDC |
| 2004 | Klein KC, Diehl EB — Relationship between MMR vaccine and autism | Ann Pharmacother | Review of 10 articles | No causal relationship found | Academic / no industry funding disclosed |
| 2004 | Institute of Medicine — Immunization Safety Review: Vaccines and Autism | National Academies Press | Review of 200+ studies | No causal relationship between MMR and autism; also rejected thimerosal link | US Congress / independent committee of 15 experts |
| 2005 | Honda H, et al. — No effect of MMR withdrawal on autism incidence, Yokohama | J Child Psychol Psychiatry | All children born 1988–1996, Yokohama, Japan | ASD cases increased after MMR was withdrawn in Japan | Japanese government / Yokohama Rehabilitation Center |
| 2006 | Doja A, Roberts W — Immunizations and autism: Literature review | Can J Neurol Sci | Literature review | Overwhelming majority of studies found no MMR-autism link; no thimerosal evidence either | Canadian academic / no industry funding |
| 2006 | Richler J, et al. — Is there a regressive phenotype of ASD associated with MMR? | J Autism Dev Disord | Multi-site CPEA study, US | No link between regression in ASD and MMR; atypical development preceded vaccination | US NIH / CPEA network |
| 2007 | Uchiyama T, et al. — MMR vaccine and regression in ASD: Negative results from Japan | J Autism Dev Disord | 904 ASD patients, Japan | No significant difference in regression between vaccinated and unvaccinated | Japanese academic institutions |
| 2008 | Baird G, et al. — Measles vaccination and antibody response in ASD | Arch Dis Child | 98 ASD + 142 controls, UK | No different immune response to measles vaccine in ASD children | UK Medical Research Council |
| 2008 | Hornig M, et al. — Lack of association between measles virus vaccine and autism with enteropathy | PLoS ONE | 25 ASD + 13 controls | No measles virus found in gut tissue linked to autism | US NIH; notably, Hornig is at Columbia University — this study was a direct re-test of Wakefield's original claim |
| 2010 | Budzyn D, et al. — Lack of association between MMR and autism in children | Pediatr Infect Dis J | 96 autism + 192 controls, Poland | No causal relationship; vaccinated children had lower autism risk | Polish academic institutions |
| 2015 | Jain A, et al. — Autism occurrence by MMR status among US children with and without autistic siblings | JAMA | 95,727 children, US | No harmful association between MMR and ASD risk, even in high-risk siblings | US NIH / Lewin Group; no vaccine manufacturer funding |
| 2019 | Hviid A, et al. — MMR vaccination and autism: Nationwide cohort study | Ann Intern Med | 650,000+ Danish children born 1999–2010 | No increased risk of autism in vaccinated children; no clustering after vaccination | Danish government (Statens Serum Institut); no industry funding |
Thimerosal (Mercury Preservative) and Autism
| Year | Study | Journal | Population | Finding | Funding / Independence |
|---|---|---|---|---|---|
| 2003 | Stehr-Green P, et al. — Autism and thimerosal-containing vaccines: Lack of consistent evidence | Am J Prev Med | Ecological comparison: California, Sweden, Denmark | Autism rates rose in all three countries regardless of thimerosal exposure trends | US CDC / academic |
| 2003 | Hviid A, et al. — Association between thimerosal-containing vaccine and autism | JAMA | 467,000 children, Denmark | Same autism risk whether thimerosal-containing or thimerosal-free vaccine was used | Danish Statens Serum Institut / no industry funding |
| 2003 | Madsen KM, et al. — Thimerosal and autism: Negative ecological evidence from Denmark | Pediatrics | National Danish registry | Autism incidence increased after thimerosal was removed from vaccines in Denmark | Danish government |
| 2004 | Heron J, et al. — Thimerosal exposure in infants and developmental disorders, UK | Pediatrics | 14,000+ children, UK | No negative effect of early thimerosal exposure on neurological or psychological outcomes | UK Medical Research Council / Avon Longitudinal Study |
| 2006 | Fombonne E, et al. — Pervasive developmental disorders in Montreal and links with immunizations | Pediatrics | 28,000 children, Montreal | Thimerosal and MMR not linked to PDD prevalence | Canadian Institutes of Health Research |
| 2007 | Thompson WW, et al. — Early thimerosal exposure and neuropsychological outcomes at 7–10 years | NEJM | 1,047 children, US | No causal association between early thimerosal exposure and neuropsychological deficits | US CDC; no vaccine manufacturer funding |
| 2008 | Schechter R, et al. — Continuing increases in autism reported to California's system | Arch Gen Psychiatry | California DDS data, 1995–2007 | Autism cases continued to rise after thimerosal removal from vaccines | California Department of Public Health |
| 2010 | Price C, et al. — Prenatal and infant exposure to thimerosal and risk of autism | Pediatrics | 256 ASD + 752 controls, US | No increased autism risk from prenatal or infant thimerosal exposure | US CDC; independent managed-care organization data |
Vaccine Schedule, Antigens, and Cumulative Exposure
| Year | Study | Journal | Population | Finding | Funding / Independence |
|---|---|---|---|---|---|
| 2010 | Smith M, Woods C — On-time vaccine receipt in first year does not adversely affect neuropsychological outcomes | Pediatrics | 1,000+ children born 1993–97, US | No negative effect on 42 neuropsychological tests at age 7–10; timely vaccination associated with better outcomes | US CDC / Vaccine Safety Datalink |
| 2013 | DeStefano F, et al. — Increasing vaccine antigen exposure not associated with autism risk | J Pediatrics | 321 ASD + 752 controls, US | No association between number of vaccine antigens received and ASD diagnosis | US CDC |
| 2015 | Jain A, et al. (see above) | JAMA | 95,727 children | Covers schedule and sibling risk | US NIH |
Systematic Reviews and Meta-Analyses
These are the most methodologically rigorous studies — they aggregate and re-analyze the primary research using defined inclusion criteria.
| Year | Study | Journal | Scope | Finding | Notes |
|---|---|---|---|---|---|
| 2004 | Institute of Medicine — Immunization Safety Review: Vaccines and Autism | National Academies Press | 200+ studies; 15-expert independent committee | No causal relationship: MMR or thimerosal → autism | Commissioned by US Congress; fully independent of vaccine manufacturers |
| 2014 | Taylor LE, et al. — Vaccines are not associated with autism: Evidence-based meta-analysis | Vaccine | 5 cohort studies (1.26M children) + 5 case-control studies (9,920 children) | No relationship: vaccines, MMR, thimerosal, or mercury → ASD | Australian academic (University of Sydney); no industry funding disclosed |
| 2021 | AHRQ — Safety of vaccines used for routine immunization in the US: Updated systematic review | AHRQ Publication No. 21-EHC024 | Update of 2014 review; 338 studies across vaccine safety questions | No new evidence of increased risk from routine childhood vaccinations | US government (Agency for Healthcare Research and Quality); fully independent |
| 2021 | Cochrane Review — Vaccines for measles, mumps, rubella, and varicella in children | Cochrane Database Syst Rev | Comprehensive systematic review | MMR vaccination not associated with autism | Cochrane Collaboration; independent, non-industry |
| 2025 | WHO GACVS — Vaccines, thimerosal and autism spectrum disorder: Evidence review 2010–2025 | WHO | 31 primary studies, 2010–2025, multiple countries | No causal link between vaccines and ASD; confirms no association with thimerosal or aluminum adjuvants | WHO Global Advisory Committee on Vaccine Safety; fully independent |
A Note on Funding and Independence
This is the question that matters most to skeptics, and it deserves a direct answer.
Who funded this research?
The research comes from a wide range of funders across multiple countries:
- National governments and public health agencies: The Danish Statens Serum Institut, the UK Medical Research Council, the US CDC, the US NIH, Finnish and Japanese national health institutes, and the Canadian Institutes of Health Research have all funded major studies. These are government bodies, not pharmaceutical companies.
- Independent academic institutions: Studies from Columbia University, the University of Sydney, the University of Bristol (Avon Longitudinal Study), and others were funded through standard academic grants.
- Independent review bodies: The US Institute of Medicine (now National Academy of Medicine), the Cochrane Collaboration, the WHO's Global Advisory Committee on Vaccine Safety, and the Agency for Healthcare Research and Quality are structurally independent of vaccine manufacturers.
The key point: the largest and most-cited studies — the 537,000-child Danish MMR study (NEJM, 2002), the 650,000-child Danish cohort (Ann Intern Med, 2019), the 95,727-child US sibling study (JAMA, 2015), and the meta-analyses — were funded by government agencies or academic bodies with no pharmaceutical industry involvement.
Are any studies industry-funded?
Some smaller studies and some vaccine ingredient studies were conducted by researchers affiliated with vaccine manufacturers or used manufacturer-supplied data. This is worth noting, and it is why independent replication matters. In this case, the independent replications — including the Cochrane review, the Institute of Medicine review, and the WHO 2025 analysis — reach identical conclusions.
The "conflict of interest" argument cuts both ways
Anti-vaccine advocates frequently argue that vaccine researchers have conflicts of interest. But the same scrutiny should apply to the anti-vaccine claim. The original 1998 Wakefield paper — the source of the entire controversy — was funded in part by lawyers preparing a lawsuit against vaccine manufacturers. Wakefield had filed for a patent on a rival measles vaccine before publishing. The paper was retracted in 2010 and Wakefield lost his medical licence. The BMJ called it an "elaborate fraud." That conflict of interest was not theoretical.
The Origin of the Myth: Wakefield 1998
The vaccine-autism hypothesis has a specific, traceable origin. In 1998, Andrew Wakefield and 12 co-authors published a paper in The Lancet claiming a link between the MMR vaccine, bowel disease, and autism in 12 children. The study:
- Involved only 12 children — far too small to establish causation
- Was later found to have manipulated data and misrepresented the children's clinical histories
- Was funded in part by lawyers preparing litigation against vaccine manufacturers
- Led to Wakefield holding a patent application for a rival single measles vaccine at the time of publication
The paper was retracted by The Lancet in 2010. Ten of the 13 co-authors withdrew their names. The UK General Medical Council found Wakefield guilty of serious professional misconduct. Before retraction, it had been cited over 600 times — a textbook case of how misinformation spreads through legitimate citation before the underlying fraud is exposed.
The myth it generated, however, proved more durable than the evidence that debunked it.
What Actually Causes Autism?
The research consensus is that autism is strongly genetic in origin, with environmental factors playing a modifying role. The Autism Science Foundation summarizes the current evidence:
- Genetics: In 15–20% of cases, a single genetic variant explains autism features. In others, multiple gene variations interact. Autism runs in families strongly.
- Parental age: Higher age at conception of either parent increases risk.
- Premature birth and low birthweight: Associated with higher autism rates.
- Illness during pregnancy: Certain infections during pregnancy are associated with increased risk — notably the same diseases that vaccines prevent.
- Prenatal exposures: Certain anti-epileptic drugs and high air pollution exposure during pregnancy are associated with autism in offspring.
The timing overlap between vaccine schedules and autism diagnosis is real — both happen in the first two years of life. But timing overlap is not causation. The Japan data makes this plain: when Japan withdrew the MMR vaccine entirely in 1993, autism rates continued to climb.
Tracking Resources
If you want to go deeper, these are the most useful public starting points:
| Resource | What it contains |
|---|---|
| AAP / HealthyChildren.org — Vaccine Safety: Examine the Evidence | Annotated list of ~35 studies with plain-language summaries |
| Autism Science Foundation — Read the Science | Categorized bibliography with Zotero library download |
| WHO GACVS — Vaccines, thimerosal and autism 2010–2025 | Most recent international review (Dec 2025) |
| AHRQ — Safety of vaccines used for routine immunization (2021) | US government systematic review of 338 studies |
| Cochrane Review — MMR, MMRV, and varicella vaccines in children (2021) | Gold-standard independent systematic review |
| National Academies Press — Immunization Safety Review: Vaccines and Autism (2004) | Independent committee review of 200+ studies; free to read online |
The Bottom Line
The "40 studies / 5.6 million people" figure is not a precisely enumerated list with a fixed registry — it is a reasonable summary of a research record that now spans nearly three decades, multiple countries, and tens of millions of children. The research has been conducted and funded primarily by governments and independent academic institutions, not pharmaceutical companies. The independent reviews — including Cochrane, the US Institute of Medicine, and the WHO — reach the same conclusion as the primary studies.
The hypothesis being tested has not changed. The answer has not changed either.